NCT05098041View on ClinicalTrials.gov

A Study of Soticlestat and Rifampin in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

February 16, 2022

Study Completion Date

March 3, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Soticlestat

Soticlestat tablets.

DRUG

Rifampin

Rifampin capsules.

Trial Locations (1)

BT9 6AD

Celerion, Belfast

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY